HOME >> BIOLOGY >> NEWS
DFG To Set Up 14 New Collaborative Research Centres

in a cell dysfunction and thus cause diseases; this is why their study is of particular interest to basic medical science. Against the backdrop of clinically relevant disease models such as cancer, atherosclerosis, psoriasis or multiple sclerosis which are the result of dysregulated or defective signal pathways the new collaborative research centre to be set up at Kiel University will explore the "Specificity and pathophysiology of signal transduction pathways".

Even though the incidence of pancreatic diseases is increasing, there has been no possibility to date to manage and influence the chronic inflammatory process and stop the development of fibrosis resulting in severe chronic pain, pancreatic insufficiency and secondary diabetes mellitus. At the same time, chronic pancreatitis constitutes a cancer risk. This is why scientists at the collaborative research centre "Inflammation, regeneration and transformation of the pancreas " at Ulm University plan to investigate the mechanisms of inflammation, monitor repair and regeneration processes in changed pancreatic tissue and focus on the complex molecular mechanisms of pancreatic carcinoma. This may provide the basis for a potential immunotherapy.

Natural sciences

Non-linear processes are common in nature and technology, but are mainly related to lowdimensional systems. There is still a considerable need for research into real - typically highdimensional - systems. The collaborative research centre "Complex non-linear processes. Analysis - simulation - control - optimisation" to be set up at Berlin's Humboldt University will focus on the analysis of space-time structures from the perspectives of theoretical and experimental physics as well as applied mathematics, e.g. with regard to processes in many-particle systems, in chemically reactive systems, especially in surfaces or in dynamic structures in semiconductors. The scientists intend to identify commonalities and explore to what extent these
'"/>

Contact: Dr. Pia Teufel
teufel@pr.dfg.d400.de
49-228-885-2376
Deutsche Forschungsgemeinschaft
19-Jun-1998


Page: 1 2 3 4 5 6 7 8

Related biology news :

1. Collaborative research initiative aims to cut drug development time in half
2. Army awards up to $50 million to establish Institute for Collaborative Biotechnologies
3. Collaborative grant to Rutgers and Rep. of Georgia for salmonella research
4. NIMH awards $22.6 million for Center for Collaborative Research on Mental Disorders
5. Researchers determine genetic cause of Timothy syndrome
6. Researchers find color sensitive atomic switch in bacteria
7. Schepens Eye Research Institute receives Roadmap grant to develop center for curing eye diseases
8. Researchers identify protein promoting vascular tumor growth
9. Researchers devise potent new tools to curb ivory poaching
10. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
11. Researchers ID chlorophyll-regulating gene

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: DFG Set New Collaborative Research Centres

(Date:7/23/2014)... Chrysomya megacephala is commonly found in dead bodies ... time of death, referred to as the post mortem ... C. megacephala from Tamil Nadu is provided for ... characterization through generation of DNA barcoding. This study, significant ... Biodiversity Data Journal . , Chrysomya megacephala ...
(Date:7/23/2014)... New Rochelle, NY -- The potential for clinical ... for transplant-based therapeutic strategies has previously been hindered ... the development of tumors. The ability to use ... for the treatment of heart disease, specifically acute ... Stem Cells and Development , a peer-reviewed ...
(Date:7/23/2014)... MINNETONKA, Minn. , July 23, 2014 /PRNewswire/ ... technology company specializing in clinical study management systems, ... West , a proven life sciences industry executive ... named Chief Operating Officer (COO).  Clareece will be ... and sales growth, operational efficiency and quality product/service ...
Breaking Biology News(10 mins):Dead body feeding larvae useful in forensic investigations 2MedNet Appoints Clareece West As Chief Operating Officer 2
(Date:7/23/2014)... July 23, 2014 ... of Trendlines Agtech , announced it has ... Israel,s leading agricultural thermoplastics applications companies. ... Valentis,s technology combines nanocrystalline cellulose (NCC), a biodegradable, ... additional nanoparticles to produce highly improved polymeric films. ...
(Date:7/23/2014)... regulated information -- UCB today announced an important advance ... topline results from the latest Phase 3 study ... evaluate the efficacy and safety of brivaracetam ... to placebo, as adjunctive treatment in adult focal ... despite treatment with one or two concomitant antiepileptic ...
(Date:7/23/2014)... 2014  Sofinnova Ventures, a Menlo Park ... of Sofinnova Venture Partners IX, L.P. at the hard ... initial fund target of $425 million. Sofinnova ... Consistent with recent funds, SVP IX will provide capital ... along with select investments in earlier stage opportunities. Investments ...
(Date:7/23/2014)... 2014 OncLive® is pleased to ... joined its Strategic Alliance Partnership program. , ... UNC Lineberger will have the opportunity to work ... its cutting-edge research initiatives, community-directed cancer prevention programs, ... work with OncLive to educate their peers by ...
Breaking Biology Technology:Valentis Nanotech Signs MOU to Integrate Technology in Thermoplastics Production 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 2Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 3Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 4Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 5Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 6Major advance in UCB pipeline: positive topline Phase 3 results for brivaracetam in epilepsy patients with partial-onset seizures 7Sofinnova Raises $500 Million Biotech Venture Fund 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 2OncLive Expands Its Strategic Alliance Partnership Program With the Addition of UNC Lineberger Comprehensive Cancer Center 3
Cached News: